You just read:

Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing Its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase III Osteoporosis Treatment Trial

News provided by

Tarsa Therapeutics

Sep 19, 2011, 07:00 ET